Prescriber Scope of Practice for Depression in New York

If you’re a psychiatrist or PMHNP considering telehealth, you’re probably asking the same question your patients are: Can I actually prescribe medications through video visits? The short answer in 2025 is yes — with some important caveats about federal DEA rules, state-specific laws, and your scope of practice.

Let’s cut through the confusion. The regulatory landscape for telehealth prescribing has been in flux since COVID, and many providers are still operating on outdated assumptions. Here’s what actually matters for your practice right now.

Federal Rules: DEA Extensions Through 2026 (For Now)

Here’s the deal: Until December 31, 2026, you can prescribe controlled substances via telehealth without an in-person exam, thanks to the DEA’s fourth temporary extension of COVID-era flexibilities. This means you can initiate treatment for depression, anxiety, ADHD, or any other psychiatric condition via video visit and prescribe whatever medications are clinically appropriate — including Schedule II stimulants like Adderall.

This is a huge deal for psychiatric practice. Under normal circumstances, the Ryan Haight Act requires an in-person evaluation before prescribing any controlled substance via telemedicine. But that requirement has been suspended since March 2020, and the DEA keeps extending it because pulling the plug would cut off millions of patients from necessary psychiatric care.

What’s coming next? The DEA announced proposed rules in January 2025 that would create a permanent framework for telehealth prescribing. The most relevant piece for psychiatrists: a new ‘Advanced Telemedicine Prescribing’ registration specifically for board-certified psychiatrists (and a few other specialists) that would allow Schedule II prescribing via telehealth without in-person requirements. For Schedule III–V drugs, a more general telemedicine registration would apply to all prescribers.

The catch? These are proposed rules currently open for public comment. They won’t be finalized until late 2026 at the earliest. So for now, you’re operating under the temporary extension — which means you should document that you’re prescribing under the COVID-era DEA policy and stay alert for changes.

For routine depression treatment, this rarely matters. SSRIs, SNRIs, bupropion, mirtazapine — none of these are controlled substances. You can prescribe them via telehealth with zero federal restrictions, just like you would in person. The DEA rules only kick in when you’re managing comorbid conditions that require controlled medications: benzos for anxiety, stimulants for ADHD, sleep aids like Ambien, or off-label treatments like low-dose ketamine.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Your Scope of Practice: MD/DO vs PMHNP

Your professional credentials determine how you can prescribe via telehealth, especially when it comes to supervision requirements.

Psychiatrists (MD/DO): You have full prescriptive authority in all states. No supervision required, no collaborative agreements, no artificial limits on what you can prescribe for depression or any psychiatric condition. The only requirements are the usual ones: you must be licensed in the state where the patient is located, hold a valid DEA registration, and follow standard-of-care protocols (documentation, informed consent, PDMP checks for controlled substances).

The upcoming DEA special registration for Schedule II telehealth prescribing? It’s designed for you. Psychiatrists would be explicitly allowed to prescribe stimulants, certain pain medications, and other Schedule IIs via telehealth under the proposed framework. This acknowledges what’s already obvious: psychiatric medication management often requires access to the full pharmacopeia.

PMHNPs (Psychiatric Mental Health Nurse Practitioners): Your scope varies significantly by state, and this is where things get complicated. You’re fully trained to diagnose and treat depression, prescribe medications, and provide comprehensive psychiatric care — but whether you can do that independently via telehealth depends entirely on where you’re practicing.

Full practice authority states — think California (as of 2024), New York, Illinois — allow experienced PMHNPs to practice without physician supervision. In these states, you can join a telehealth platform, see patients independently, and prescribe antidepressants, anxiolytics, and (where permitted by federal law) controlled substances on your own authority.

Restricted practice states — Texas, Florida, Pennsylvania — require you to maintain a collaborative agreement with a physician. Texas requires monthly meetings and documented oversight. Florida explicitly excludes psychiatric NPs from its autonomous practice law (which only applies to primary care specialties). Pennsylvania requires a collaborative agreement on file with the Board of Nursing.

This isn’t just administrative paperwork. In restricted states, you’ll need a supervising psychiatrist involved in your telehealth practice — at least on paper. Some platforms handle this by pairing NPs with collaborating physicians as part of their credentialing process. Others require you to arrange your own supervision.

The scope difference in practice: For routine depression management (SSRIs, therapy referrals, basic medication adjustments), psychiatrists and PMHNPs operate identically. The differences emerge with controlled substances and complex cases. Even in full-practice states, the upcoming DEA rules might restrict PMHNPs from prescribing Schedule II drugs via telehealth if the patient has never been seen in person — that special registration appears to be limited to physicians. So if you’re an NP planning to manage ADHD or treatment-resistant depression requiring stimulant augmentation, pay attention to how those final rules shake out.

State-Specific Prescribing Rules: Where It Gets Messy

Federal DEA policy sets the floor, but states can (and do) add their own telehealth prescribing requirements. Here’s what you need to know about the major markets:

California: Open for Business (Especially for NPs)

California is one of the most telehealth-friendly states. There’s no state requirement for an in-person exam before prescribing via telehealth. As long as your video evaluation meets the standard of care, you can prescribe antidepressants, anxiolytics, or (under current DEA rules) controlled substances.

The game-changer here is AB 890, which created a pathway for experienced NPs to practice independently. As of January 2024, qualified PMHNPs can become ‘104 NPs’ with full independent practice authority statewide. That means no physician oversight, no collaborative agreement — you can run your own telehealth practice just like a psychiatrist.

The catch: California is not part of the Interstate Medical Licensure Compact. You need a full California license to treat patients there, whether you’re a psychiatrist or NP. No shortcuts, no temporary registrations. Given California’s high cost of living and significant demand in inland and rural areas, the juice is usually worth the squeeze.

Texas: Video Required, Chronic Pain Prohibited

Texas modernized its telemedicine laws in 2017 (SB 1107), eliminating the old requirement for an in-person visit before establishing a patient relationship. Now you can see a new patient via live video and prescribe medication based on that encounter.

Key restriction: You must use audio-visual telemedicine for new patients. Phone-only visits generally don’t cut it under Texas Medical Board rules unless you’re doing a follow-up. For depression treatment, just use video and you’re fine.

The bigger issue: Texas explicitly prohibits treating chronic pain with controlled substances via telemedicine unless stringent conditions are met (like a recent in-person visit within 90 days). This is aimed at opioid prescribing, but it’s written broadly enough that you should be cautious if a patient’s depression overlaps with chronic pain management. Prescribing a benzo for anxiety or a stimulant for ADHD? Not an issue — the chronic pain rule doesn’t apply to psychiatric treatment.

For NPs in Texas: You’re not independent here. All APRNs need a written Prescriptive Authority Agreement with a physician, including monthly chart reviews and availability for consultation. There’s been legislative chatter about expanding APRN scope, but as of 2025, the supervision requirement stands.

Texas is an IMLC member, so out-of-state psychiatrists can get licensed more easily. Given the state’s 246 designated mental health shortage counties, there’s massive demand for telepsychiatry.

Florida: Psychiatric Exception for Schedule II

Florida is unusually accommodating for telepsychiatry, thanks to a specific carve-out in state law. Normally, Florida prohibits prescribing Schedule II controlled substances via telehealth — except for psychiatric disorders, inpatient hospital care, hospice, or nursing home patients.

What this means: You can prescribe Adderall, Ritalin, or other Schedule II stimulants via telehealth for depression augmentation or ADHD, because those are psychiatric conditions. You cannot prescribe Schedule IIs for non-psychiatric uses (like weight loss or chronic fatigue). Schedule III–V drugs (benzos, sleep aids, ketamine) have no telehealth restrictions.

Florida also offers an out-of-state telehealth registration option, so you don’t necessarily need a full Florida license if you’re treating patients there remotely. This has made Florida a popular market for telepsychiatry expansion.

The NP problem in Florida: Psychiatric NPs are explicitly excluded from Florida’s autonomous practice law. You need a supervising physician and a protocol agreement, even via telehealth. Florida’s only allowing primary care NPs to practice independently, so if you’re a PMHNP, you’ll need a Florida-licensed psychiatrist involved.

New York: NP Independence After 3,600 Hours

New York doesn’t impose special telehealth prescribing barriers beyond the usual standard of care. The state has strong insurance parity laws and actively encourages telepsychiatry, especially for connecting downstate providers with upstate patients.

For experienced NPs: New York’s 2022 law allows NPs with more than 3,600 hours of practice (roughly 2 years full-time) to practice without a written collaborative agreement or physician supervision. This is full independence for PMHNPs who meet the threshold — you can evaluate, diagnose, prescribe, and manage patients entirely on your own.

New York also requires electronic prescribing for all medications and has strict registration requirements. Not in the IMLC, so out-of-state psychiatrists need a full NY license.

Pennsylvania: Collaborative Agreements Required

Pennsylvania has no comprehensive telehealth statute, but the Department of State has made clear that telehealth is permissible within your scope of practice as long as it meets standard of care. Practically, this means psychiatrists can prescribe via video visits without state-imposed barriers.

NPs in PA: No independence yet. You need a collaborative agreement with a physician on file with the Board of Nursing. The physician doesn’t have to be on your video calls, but they must be available for consultation and involved in oversight.

Pennsylvania joined the IMLC in 2021, so out-of-state psychiatrists can obtain licensure more easily. The state also mandates e-prescribing for controlled substances with limited exceptions.

Illinois: Full Practice Authority Available

Illinois is provider-friendly across the board. The state passed comprehensive telehealth parity laws in 2021, explicitly allowing telehealth from any location and prohibiting insurers from requiring prior in-person visits.

For NPs: Illinois offers Full Practice Authority to APRNs (including PMHNPs) who complete 4,000 hours of collaborative practice plus additional education. With FPA, you can prescribe independently, including controlled substances. Without FPA, you need a collaborative agreement.

There’s one quirk: FPA APRNs in Illinois must have a physician consultation process in place for managing chronic Schedule II opioid prescriptions. For psychiatric practice (stimulants, benzos, etc.), this rarely matters.

Illinois also allows audio-only telehealth for behavioral health when appropriate, and the state participates in the IMLC for physician licensing.

State-by-State Comparison: Key Requirements

The Economics of Telehealth Prescribing

Let’s talk money, because that’s ultimately why you’re considering telehealth.

The DIY marketing trap: A lot of providers think they can just hang a shingle online, run some Google Ads, maybe get listed on Psychology Today, and start filling their schedule. Reality check: acquiring a qualified psychiatric patient through DIY marketing typically costs $200–500+ when you factor in all the hidden costs.

Here’s what that actually looks like:

• Google Ads: Mental health keywords cost $15–40+ per click. Most clicks don’t book. A realistic cost per booked patient is $200–400+, and that assumes you know what you’re doing with PPC.
• SEO: Takes 6–12 months of consistent investment before generating meaningful patient flow. You need content, technical optimization, backlinks — or you’re paying an agency $2,000–5,000/month to handle it.
• Directory listings: Psychology Today charges monthly fees and you’re competing with hundreds of other providers on the same page. Zocdoc charges per booking ($35–100+) plus monthly platform fees.
• Opportunity cost: Your time managing campaigns, qualifying leads, handling no-shows from cold traffic. Most solo providers underestimate this massively.

The platform alternative: Telehealth platforms like Klarity Health use a pay-per-appointment model. You pay a standard listing fee for each new patient lead, but there’s no upfront marketing spend, no monthly subscriptions, no wasted ad budget on clicks that don’t convert.

The value proposition is straightforward:

• Pre-qualified patients already matched to your specialty and availability
• Built-in telehealth infrastructure (no separate platform costs)
• Both insurance and cash-pay patient flow
• You control your schedule — only pay when you see patients
• Guaranteed ROI vs. gambling $3,000–5,000/month on marketing with uncertain results

For most providers — especially those starting out or scaling a practice — this removes the patient acquisition risk entirely. You’re not betting on SEO rankings or ad campaign performance. You’re paying for actual appointments with patients who are ready to be seen.

What This Means for Your Practice

If you’re a psychiatrist: You have maximum flexibility right now. You can prescribe anything clinically appropriate via telehealth under current DEA rules (through 2026), and the upcoming permanent regulations are being designed specifically to accommodate psychiatric practice. Focus on getting licensed in your target states, ensure you’re using compliant e-prescribing systems, and document your telehealth encounters thoroughly.

If you’re a PMHNP: Check your state’s independence rules first. In full-practice states (CA, NY, IL), you can operate autonomously and build a telehealth practice with no physician overhead. In restricted states (TX, FL, PA), you’ll need a collaborating physician — either through your own arrangement or through a platform that provides that infrastructure.

For both: The biggest mistake providers make is assuming telehealth prescribing is riskier or legally murkier than in-person care. It’s not. The standard of care is identical. You need a proper evaluation, documentation, informed consent, and appropriate follow-up. Use video when possible, check your state PDMP before prescribing controlled substances, and stay current on regulatory changes.

The regulatory environment is actually moving in your favor. The DEA’s proposed rules acknowledge that psychiatric care — including controlled substance prescribing — can be delivered safely via telehealth. States are expanding NP independence and telehealth parity. Insurance reimbursement is solidifying.

The real question isn’t can you prescribe via telehealth. It’s whether you’re positioning yourself to capitalize on the shift that’s already happened.

Frequently Asked Questions

Can I prescribe antidepressants via telehealth to a new patient I’ve never met in person?

Yes, in all states. Antidepressants (SSRIs, SNRIs, etc.) are not controlled substances, so they’re not subject to DEA telehealth restrictions. As long as your telehealth evaluation meets the standard of care for your state, you can prescribe them just like you would after an in-person visit.

What about Xanax or Ativan for a patient with depression and anxiety?

Under current DEA rules (through December 31, 2026), you can prescribe benzodiazepines via telehealth to a new patient without an in-person exam. Check your state’s specific rules (e.g., Texas requires video not just phone), document the clinical rationale, check your state PDMP, and follow your usual prescribing protocols. After 2026, you may need to obtain a DEA special telemedicine registration.

Can I prescribe Adderall via telehealth for a patient with depression and ADHD?

Yes, under current federal rules (through 2026). Some states have additional requirements — Florida explicitly allows it for psychiatric disorders, Texas has no prohibition for ADHD treatment — but you’re operating under the DEA’s temporary extension. Document thoroughly. If the patient is new to stimulants, consider whether your telehealth evaluation is sufficient to rule out contraindications (cardiac history, substance use risk, etc.).

Do I need a separate DEA registration for telehealth prescribing?

Not currently. You use your existing state DEA registration for the state where the patient is located. The upcoming permanent rules may create a special telemedicine registration, but that’s not finalized yet.

What if my state requires an in-person exam for prescribing?

Very few states currently have that requirement for psychiatric medications. Check the specific regulations for your state (see the state-by-state comparison above). Most states allow telehealth evaluations to establish a valid patient relationship for prescribing, as long as standard of care is met.

Can I treat patients in multiple states via telehealth?

Yes, but you need to be licensed (or hold a valid telehealth registration) in each state where your patients are located. The Interstate Medical Licensure Compact (IMLC) makes it easier for physicians to obtain licenses in multiple states. For NPs, some states have reciprocity agreements or are joining the APRN Compact, but coverage is limited as of 2025.

How do insurance reimbursements work for telehealth prescribing?

Most states now have telehealth parity laws requiring private insurers and Medicaid to reimburse telehealth visits at the same rate as in-person. Medicare also covers telehealth for mental health services with no geographic restrictions (a permanent change from COVID-era policies). The specific billing codes and requirements vary by payer, but telepsychiatry is generally well-reimbursed.

What happens if the DEA extension expires and I’m still treating patients who need controlled substances?

If the temporary extension expires without a permanent rule in place, you would theoretically need to see patients in person before continuing to prescribe controlled substances. However, given the DEA’s repeated extensions and ongoing rulemaking process, most experts expect either another extension or finalized permanent rules before the December 2026 deadline. Monitor DEA announcements and professional association guidance (APA, AANP, etc.) closely as that date approaches.

Ready to join a telehealth platform that handles patient acquisition so you can focus on clinical care? Explore Klarity Health’s provider network and see how we match qualified patients with psychiatrists and PMHNPs who specialize in depression treatment. No upfront marketing costs. No subscription fees. Just patients ready to be seen.

Citations

1. U.S. Department of Health and Human Services. (January 2, 2026). HHS & DEA Extend Telemedicine Flexibilities for Prescribing Controlled Medications Through 2026. https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html

2. U.S. Drug Enforcement Administration. (January 16, 2025). DEA Announces Three New Telemedicine Rules to Continue Open Access to Care and Protect Patients. https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access

3. California Board of Registered Nursing. (Updated January 2023). AB 890 – Nurse Practitioner Practice. https://www.rn.ca.gov/practice/ab890.shtml

4. Florida Statutes §456.47. (2019, updated through 2025). Use of Telehealth to Provide Services. https://www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499/0456/Sections/0456.47.html

5. Texas Administrative Code Title 22, Part 9, Rule §174.5. (Updated January 15, 2025). Telemedicine Issuance of Prescriptions. https://txrules.elaws.us/rule/title22chapter174sec.174.5

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=announced%20a%20fourth%20temporary%20extension,disruptions%20in%20care%20while%20permanent
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=registration%20is%20available%20to%20medical,V%20medications
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=These%20rules%20are%20a%20result,temporary%20rule%20until%20December%202025
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=is%20accessible%20for%20medical%20care,is%20being%20prescribed%20controlled%20medication
• https://www.rn.ca.gov/practice/ab890.shtml#:~:text=%2A%20103%20NP%20,focus%20of%20their%20National%20Certification
• https://www.rivkinrounds.com/2022/04/new-law-allows-experienced-nps-to-practice-independently-in-ny/#:~:text=New%20York%20law%20previously%20allowed,based%20on%20only
• https://txrules.elaws.us/rule/title22chapter174sec.174.5#:~:text=,person%20setting
• https://txrules.elaws.us/rule/title22chapter174sec.174.5#:~:text=,be
• https://www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499%2F0456%2FSections%2F0456.47.html#:~:text=telehealth%20to%20provide%20health%20care,in%20Schedule%20II%20of%20s
• https://txrules.elaws.us/rule/title22chapter174sec.174.5#:~:text=,through%20a%20telemedicine%20medical%20service